CD274 and neoplasm: In detail, PD-L1 expression ranging from 23–92% of tumor cells in TMs and 36–100% of tumor cells in TCs [69]; variations in protein expression levels are related to various conditions, particularly disease stage (Masaoka stages) and subtype of TETs, with higher levels observed in thymic [70].